Creative Medical Technology Holdings CELZ
NASDAQ CELZ
$1.04 -0.04 (-3.70%)
At close: Sep 9, 2026 · 4:00 PM EDT

Creative Medical Technology Holdings (CELZ) Non-Current Assets (2016 - 2026)

Creative Medical Technology Holdings' (CELZ) quarterly Non-Current Assets came in at $358740.0 in Q2 2026, down 24.08% year-over-year from $472521.0 in Q2 2025, and down 6.0% quarter-over-quarter from $381658.0 in Q1 2026.

Analysis

Creative Medical Technology Holdings (CELZ) Non-Current Assets (2016 - 2026) Analysis & Trends

Creative Medical Technology Holdings (CELZ) has reported Non-Current Assets for 11 consecutive years, with $358740.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Non-Current Assets fell 24.08% year-over-year to $358740.0 in Q2 2026; TTM through Jun 2026 was $1.6 million, a 22.93% decrease from a year earlier, with the FY2025 full-year figure at $410511.0, down 23.1% from the prior year.
  • Non-Current Assets was $358740.0 for Q2 2026 at Creative Medical Technology Holdings, down from $381658.0 in the prior quarter.
  • Over five years, Non-Current Assets peaked at $556479.0 in Q3 2024 and troughed at $358740.0 in Q2 2026.
  • A 5-year average of $448648.3 and a median of $442877.0 in 2023 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets grew 22.49% in 2025 and decreased 24.16% in 2026, its largest moves.
  • Over 5 years, Non-Current Assets stood at $438876.0 in 2022, then grew by 1.23% to $444292.0 in 2023, then rose by 20.16% to $533840.0 in 2024, then declined by 23.1% to $410511.0 in 2025, then retreated by 12.61% to $358740.0 in 2026.
  • The last three Non-Current Assets figures came in at $358740.0 (Q2 2026), $381658.0 (Q1 2026), and $410511.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Krystal Biotech 10.60 Bn 9.76 Bn 112.79 Mn 441.00 Mn
2 CRISPR Therapeutics AG 5.39 Bn 5.39 Bn - 279.00 Mn
3 Iovance Biotherapeutics 3.98 Bn 3.68 Bn 55.72 Mn 451.27 Mn
4 Legend Biotech 3.97 Bn 3.00 Bn 251.50 Mn 523.50 Mn
5 uniQure 3.09 Bn 3.09 Bn 5.49 Mn 150.83 Mn
6 Beam Therapeutics 3.06 Bn 3.06 Bn - 207.76 Mn
7 Precigen 2.54 Bn 2.54 Bn 52.17 Mn 35.91 Mn
8 Sarepta Therapeutics 2.38 Bn 1.58 Bn 251.87 Mn 964.69 Mn
9 Vericel 2.06 Bn 1.89 Bn 56.40 Mn 238.14 Mn
10 Creative Medical Technology Holdings 1.48 Mn 1.50 Mn - 358,740.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 358,740.00
Mar 31, 2026 381,658.00
Dec 31, 2025 410,511.00
Sep 30, 2025 441,462.00
Jun 30, 2025 472,521.00
Mar 31, 2025 503,263.00
Dec 31, 2024 533,840.00
Sep 30, 2024 556,479.00
Jun 30, 2024 385,750.00
Mar 31, 2024 415,021.00
Dec 31, 2023 444,292.00
Sep 30, 2023 469,813.00
Jun 30, 2023 392,834.00
Mar 31, 2023 415,855.00
Dec 31, 2022 438,876.00
Sep 30, 2022 461,897.00
Jun 30, 2022 484,918.00
Mar 31, 2022 507,939.00
Dec 31, 2021 530,960.00
Sep 30, 2021 553,982.00